Chemical activators of Myosin-XVA play a crucial role in its regulation and function within cellular processes. ATP is a primary activator, as it binds to Myosin-XVA and provides the necessary energy for the motor domain of the protein to interact with actin filaments. This interaction is essential for the conformational changes that drive motility and transport within cells. Magnesium ions complement this process by binding to the ATPase domain of Myosin-XVA, facilitating the hydrolysis of ATP, which further provides energy for the protein's movement along actin filaments. Actin itself serves as a critical component in this activation by providing the structural track for Myosin-XVA to navigate through its motor functions.
In conjunction with these activators, calcium ions and calmodulin form a regulatory complex that is instrumental in the activation of Myosin-XVA. Calcium ions bind to calmodulin, which then activates myosin light chain kinase (MLCK). MLCK, in turn, phosphorylates the myosin light chain, an essential step for the activation of Myosin-XVA's ATPase activity, which is vital for muscle contraction and motility. Phosphatidylinositol 4,5-bisphosphate (PIP2) also participates in the activation by binding to the pleckstrin homology domain of Myosin-XVA, aiding in its localization to the plasma membrane where it executes its functional role. Forskolin activates Myosin-XVA indirectly by increasing the levels of intracellular cAMP, which activates protein kinase A (PKA). PKA can then phosphorylate various targets that promote actin polymerization, ultimately facilitating Myosin-XVA's activity. Actin filament stabilization is a common theme in the activation of Myosin-XVA, with chemicals like phalloidin and jasplakinolide enhancing its activity by preventing actin depolymerization, ensuring a stable track for Myosin-XVA. Additionally, zinc ions may activate Myosin-XVA by stabilizing the protein structure, and blebbistatin can enhance its function by inhibiting competing myosins, thus indirectly promoting Myosin-XVA's binding to actin.
SEE ALSO...
Items 1 to 10 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates Myosin-XVA indirectly by increasing intracellular cAMP levels, which in turn activate protein kinase A (PKA). PKA can phosphorylate downstream targets that are involved in actin polymerization and myosin activation, thus impacting Myosin-XVA's role in cellular motility processes. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $53.00 | ||
ATP activates Myosin-XVA by providing the energy required for the motor domain of the protein to interact with actin filaments, which results in the conformational changes necessary for motility and transport functions within the cell. | ||||||
Calcium | 7440-70-2 | sc-252536 | 5 g | $209.00 | ||
Calcium ions activate Myosin-XVA by binding to calmodulin, which then interacts with the myosin light chain kinase to phosphorylate the myosin light chain, a process that is essential for the activation of myosin ATPase activity and consequent muscle contraction. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, elevating cAMP and cGMP levels, which might affect Myosin XVA indirectly via cAMP/cGMP-mediated signaling pathways. | ||||||
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $232.00 | ||
Calmodulin, when bound to calcium ions, activates Myosin-XVA by enabling the phosphorylation of the myosin light chain through activation of myosin light chain kinase, which is a prerequisite for myosin's motor activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), involved in numerous signaling pathways that could indirectly influence Myosin XVA activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting Myosin XVA indirectly through calcium-dependent signaling pathways. | ||||||
Lamotrigine | 84057-84-1 | sc-201079 sc-201079A | 10 mg 50 mg | $118.00 $476.00 | 1 | |
Myosin light chain kinase activates Myosin-XVA by phosphorylating the regulatory light chain of myosin, which is necessary for initiating myosin motor activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can mimic cAMP′s effects in cells, potentially influencing Myosin XVA activity through cAMP-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore which elevates intracellular calcium, potentially affecting Myosin XVA through calcium signaling. | ||||||